You have 9 free searches left this month | for more free features.

Cabergoline

Showing 1 - 25 of 81

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lactation Suppressed Trial in Stanford (Cabergoline 1 MG, Placebo)

Not yet recruiting
  • Lactation Suppressed
  • Cabergoline 1 MG
  • Placebo
  • Stanford, California
    Stanford University
Sep 1, 2023

Polycystic Ovary Syndrome Trial in Al Qadisiyah (Metformin Hydrochloride 500 MG, Cabergoline 0.5 MG, Metformin Hydrochloride 500

Completed
  • Polycystic Ovary Syndrome
  • Metformin Hydrochloride 500 MG
  • +2 more
  • Al Qādisīyah, Al-Qādisiyyah Governorate, Iraq
    Maternity and Pediatric Teaching Hospital
Jul 31, 2023

Lactation Suppressed Trial in Afula (Cabergoline, Pyridoxine)

Completed
  • Lactation Suppressed
  • Afula, Israel
    HaEmek Medical Center
Nov 10, 2022

Lactation Suppressed Trial in Stanford (Cabergoline 1 MG, Placebo)

Active, not recruiting
  • Lactation Suppressed
  • Cabergoline 1 MG
  • Placebo
  • Stanford, California
    Stanford University
Jul 7, 2022

Pituitary Tumors, Adenoma Trial in Oslo, Trondheim, Gøteborg (cabergoline)

Recruiting
  • Pituitary Neoplasms
  • Adenoma
  • cabergoline
  • Oslo, Norway
  • +2 more
Jan 19, 2023

Lactation Suppressed, Second Trimester Abortion Trial in Chicago (Cabergoline, Placebo)

Not yet recruiting
  • Lactation Suppressed
  • Second Trimester Abortion
  • Cabergoline
  • Placebo
  • Chicago, Illinois
    Northwestern Medical Center
Nov 7, 2023

Factors and Outcomes Associated With Postpartum Cabergoline Use

Recruiting
  • Lactation Suppressed
  • +3 more
    • Netanya, Israel
      Laniado Hospital, The Betty Retter Mother & Baby Medical Center
    Sep 27, 2021

    Infertility, Female Trial in Las Vegas (Cabergoline Pill)

    Completed
    • Infertility, Female
    • Cabergoline Pill
    • Las Vegas, Nevada
      Fertility Center of Las vegas
    Jun 11, 2021

    Endometriosis Trial in Boston (Cabergoline 0.5 MG, Placebo - Cap)

    Recruiting
    • Endometriosis
    • Cabergoline 0.5 MG
    • Placebo - Cap
    • Boston, Massachusetts
    • +1 more
    Mar 16, 2021

    Pituitary Adenoma, Prolactinoma, Pituitary Tumor Trial in Seoul (Cabergoline)

    Recruiting
    • Pituitary Adenoma
    • +3 more
    • Cabergoline
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Mar 17, 2020

    Cushings Disease Trial in Worldwide (Pasireotide with or without cabergoline)

    Terminated
    • Cushings Disease
    • Pasireotide with or without cabergoline
    • Birmingham, Alabama
    • +28 more
    Aug 28, 2020

    Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Chicago (cabergoline)

    Completed
    • Recurrent Breast Cancer
    • Stage IV Breast Cancer
    • cabergoline
    • Chicago, Illinois
      Northwestern University
    Sep 4, 2019

    Endometriosis Trial in Boston (Cabergoline, Norethindrone acetate)

    Completed
    • Endometriosis
    • Cabergoline
    • Norethindrone acetate
    • Boston, Massachusetts
      Children's Hospital Boston
    Jan 27, 2020

    Cushing's Disease, Acromegaly, Neuroendocrine Tumors Trial in Worldwide (Pasireotide, Cabergoline)

    Active, not recruiting
    • Cushing's Disease
    • +8 more
    • La Jolla, California
    • +93 more
    May 19, 2022

    OHSS Trial in Giza (Cabergoline, Calcium gluconate)

    Completed
    • OHSS
    • Cabergoline
    • Calcium gluconate
    • Giza, Egypt
    • +1 more
    Dec 25, 2018

    Lactation Suppressed Trial in Warsaw (Bromocriptine, Cabergoline, Natural methods)

    Unknown status
    • Lactation Suppressed
    • Warsaw, Poland
      Żelazna Medical Centre
    Jul 26, 2019

    Estetrol/Drospirenone to Reduce Average Size of Endometriomas

    Not yet recruiting
    • Ovarian Endometrioma
    • Endometrioma
      • Montreal, Quebec, Canada
        McGill University Health Center
      Apr 27, 2023

      Diabetes Trial in Cairo (Cabergoline, Gliclazide)

      Unknown status
      • Diabetes
      • Cairo, Egypt
        Sherief Abd-Elsalam
      Aug 23, 2018

      Ovarian Hyperstimulation Syndrome Trial in Singapore (Cabergoline, Placebo)

      Completed
      • Ovarian Hyperstimulation Syndrome
      • Cabergoline
      • Placebo
      • Singapore, Singapore
        KK Women's and Children's Hospital
      Aug 5, 2018

      Parkinson Disease Trial in France (Surgery under general anesthesia with experimental targeting, Usual Surgery)

      Recruiting
      • Parkinson Disease
      • Surgery under general anesthesia with experimental targeting
      • Usual Surgery
      • Amiens, France
      • +9 more
      May 31, 2022

      Resistance, Disease, Prolactinoma Trial in China (HCQ/CQ and CAB combined treatment)

      Unknown status
      • Resistance, Disease
      • Prolactinoma
      • HCQ/CQ and CAB combined treatment
      • Beijing, Beijing, China
      • +8 more
      Oct 14, 2018

      Infertility Trial (Clomiphene Citrate 50mg, Cabergoline Oral Tablet, Placebo Oral Tablet)

      Unknown status
      • Infertility
      • Clomiphene Citrate 50mg
      • +2 more
      • (no location specified)
      May 26, 2018

      Cushing Disease Trial in France (Patient group, Remission control group, Bilateral surrenalectomy control group)

      Recruiting
      • Cushing Disease
      • Patient group
      • +2 more
      • Caen, France
      • +6 more
      Dec 16, 2021

      Ovarian Hyperstimulation Syndrome Trial in Cairo (Late Cabergoline 0.5mg, Early Cabergoline 0.5mg)

      Unknown status
      • Ovarian Hyperstimulation Syndrome
      • Late Cabergoline 0.5mg
      • Early Cabergoline 0.5mg
      • Cairo, Egypt
        IVF department in Kasr Alaini hospital,private IVF centre
      Apr 8, 2018

      Ovarian Hyperstimulation Trial in Cairo (Oral Cabergoline, Calcium Gluconate)

      Completed
      • Ovarian Hyperstimulation
      • Oral Cabergoline
      • Calcium Gluconate
      • Cairo, Elqalopia, Egypt
        Ashraf nassif Elmantwe
      Mar 27, 2018